Status:
UNKNOWN
The Platform for Interdisciplinary Cardiovascular-metabolic-neurovascular Diseases (PICMAN)
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Cardiometabolic Syndrome
Eligibility:
All Genders
21-70 years
Brief Summary
Background Changes in metabolism and mitochondrial function appear to precede cardiac dysfunction, with much evidence supporting metabolic dysregulation as one of the earliest precursors of cardiovasc...
Detailed Description
Aims 1. Define norms for metabolic flexibility in a multi-ethnic Southeast Asian cohort of individuals without manifest ASCVD 2. Understand the association of metabolic inflexibility with cardiovascu...
Eligibility Criteria
Inclusion
- Patients aged 21-70 at screening
- 10-year ASCVD risk \> 5% measured by QRISK 3 calculator
Exclusion
- Established DM (Prior diagnosis, long term medications or HbA1c \>=6.5)
- Established CVD, such as ischemic heart disease, cerebrovascular accident, heart failure, atrial fibrillation
- Pregnancy
- Known contraindications to CT scan, such as allergy to contrast
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06062836
Start Date
April 1 2022
End Date
April 1 2024
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Health System
Singapore, Singapore